Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Avanos Medical (AVNS) Operating Expenses (2016 - 2026)

Avanos Medical's Operating Expenses history spans 13 years, with the latest figure at $84.9 million for Q4 2025.

  • On a quarterly basis, Operating Expenses fell 0.59% to $84.9 million in Q4 2025 year-over-year; TTM through Dec 2025 was $338.9 million, a 1.68% decrease, with the full-year FY2025 number at $338.9 million, down 1.68% from a year prior.
  • Operating Expenses hit $84.9 million in Q4 2025 for Avanos Medical, up from $83.6 million in the prior quarter.
  • Over the last five years, Operating Expenses for AVNS hit a ceiling of $99.8 million in Q2 2023 and a floor of $66.1 million in Q4 2021.
  • Historically, Operating Expenses has averaged $86.1 million across 5 years, with a median of $85.1 million in 2022.
  • Biggest five-year swings in Operating Expenses: dropped 28.0% in 2021 and later rose 29.95% in 2022.
  • Tracing AVNS's Operating Expenses over 5 years: stood at $66.1 million in 2021, then rose by 29.95% to $85.9 million in 2022, then fell by 5.36% to $81.3 million in 2023, then increased by 5.04% to $85.4 million in 2024, then decreased by 0.59% to $84.9 million in 2025.
  • Business Quant data shows Operating Expenses for AVNS at $84.9 million in Q4 2025, $83.6 million in Q3 2025, and $89.3 million in Q2 2025.